On June 22, the Scientists Forum hosted by the Nutrition Promotion Special Fund of the China Health Promotion Foundation and supported by Guangdong Shuangjun Biotechnology Co., Ltd. was successfully held in the conference center of Xijiao Hotel in Shanghai, China. With the theme of "New Discoveries of Vitamin K2 Health Evidence", the forum invited a number of well-known scientists in the fields of nutrition and medicine in China to share the latest scientific research results on the health effects of vitamin K2 on a variety of diseases, and jointly discuss their research directions and new ways of future development.
The opening of the "New Discoveries of Health Evidence for Vitamin K2" forum
Special guest of the conference
Yang Yuexin, Chairman of the Chinese Nutrition Society, Yang Xiaoguang, Vice Chairman of the Chinese Nutrition Society, Yan Weixing, Former Deputy Secretary of the Party Committee of the National Food Safety Risk Assessment Center, Li Changling, Former Vice President of the School of Pharmacy of Peking University, Xiao Hanfa, Chairman of the Supervisory Board of the China Association for Quality Management of Medicine, Professor Wang Zhu, Researcher of the Institute of Nutrition and Health of the Chinese Center for Disease Control and Prevention, Li Ying, Vice President of the School of Public Health of Harbin Medical University, and Director Yu Kang, Chief Physician of the Department of Clinical Nutrition of Peking Union Medical College Hospital. Professor Bi Qi, Chief Physician of the Department of Neurology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Director Tan Jing, Director of the Department of Hematology, Affiliated Hospital of Southwest Jiaotong University/Chengdu Third People's Hospital, Professor Ma Lihui, Chief Physician of the Department of Rheumatology and Immunology, First Affiliated Hospital of Hainan Medical College, Professor Li Shuzhuang, Department of Physiology, School of Basic Medical Sciences, Dalian Medical University, Xu Feng, Director of Shuangjun Biotin K2 Research Center/Antithrombolytic Innovative Drug Research Center, Shenyang Pharmaceutical University, Professor Zhang Meixia, School of Basic Medical Sciences, China Medical University, Professor Zhang Xiaomei of the School of Pharmacy of Jiangnan University, Professor Lin Yiguang of the University of Technology sydney in Australia, Wu Fei, Deputy Director of the Public Welfare Department of the China Health Promotion Foundation, Chen Yuan, Deputy Director of the Health Management Research and Training Center of the China Health Promotion Foundation, Wang Xin, Secretary General of the Nutrition and Health Food Branch of the Chinese Nutrition Society, Zhou Jianlie, MD of the Website of Vitamin K2 Today, and Dr. Chen Jiepeng, Chief Scientist of Shuangjun Biology.
The forum guests hosted 丨 Professor Li Changling, former vice dean of the School of Pharmacy of Peking University
Yang Yuexin, chairman of the Nutrition Promotion Special Fund of the China Health Promotion Foundation and chairman of the Chinese Nutrition Society, delivered a speech for the conference: Vitamin K2 plays a key role in human health because of its revolutionary and versatile nature. In China, the research and popularization of vitamin K2 is still in the initial stage of development, with a very large market potential. The "Vitamin K2 Public Welfare Project" was established by the Nutrition Promotion Special Fund of the China Health Promotion Foundation and Shuangjun Biology, which will continue to support vitamin K2-related research with important scientific significance, application value and feasibility in the form of project bidding, and will vigorously promote the scientific research innovation and industrial development of vitamin K2.
Speech at the conference丨Yang Yuexin, Chairman of the Chinese Nutrition Society
Expert keynote speeches
During the forum, Yu Kang, chief physician of the Department of Clinical Nutrition of Peking Union Medical College Hospital, Li Ying, deputy dean of the School of Public Health of Harbin Medical University, Tan Jing, director of the Affiliated Hospital of Southwest Jiaotong University, Professor Li Shuzhuang of Dalian Medical University, and Dr. Chen Jiepeng, chief scientist of Shuangjun Biology, delivered a multi-party speech on the theme of "New Discoveries of Vitamin K2 Health Evidence", sharing the latest discoveries of vitamin K2 on arterial calcification, type 2 diabetes, kidney disease, enteritis and other health.
Director Yu Kang, chief physician of the Department of Clinical Nutrition of Peking Union Medical College Hospital and member of the Nutrition Standards Committee of the National Health and Family Planning Commission, delivered a keynote speech on "Vitamin K2 - Leading Calcium into Bone and Reversing Arterial Calcification". Director Yu Kang pointed out that the role of vitamin K2 is comprehensive, and the study of vitamin K2 should jump out of the "calcium supplement" and see its health effects on the inside and outside of the bones. Paying attention to the overall effect of vitamin K2 is a hot topic in future clinical practice, especially nutrition, and it is hoped that through the joint efforts of scientists, effective progress in related research will be made.
Director Yu Kang delivered a speech online
Professor Li Ying, Deputy Dean of the School of Public Health of Harbin Medical University, pointed out through the keynote speech "The Effect of Vitamin K2 Supplementation on Improving the Health of Patients with Type 2 Diabetes": The phased results showed that after the vitamin K2 intervention, the homeostasis of the intestinal flora of diabetic patients was improved, and the intestinal co-metabolites underwent beneficial changes, and finally improved the blood glucose homeostasis and related health indicators of diabetic patients.
Professor Ying Li delivered a speech
Director of the Department of Hematology of the Affiliated Hospital of Southwest Jiaotong University/Chengdu Third People's Hospital, and Postdoctoral Director of Dana-Farber Cancer Center of Harvard University, delivered a speech on the theme of "Research Status and Future of Vitamin K2 Supplementation in Chronic Kidney Disease". According to reports, long-term use of drugs such as warfarin in patients with long-term nephropathy or renal dysfunction will lead to osteoporosis and vascular calcification problems, and there is still no effective intervention for vascular calcification that seriously affects cardiovascular health in chronic kidney disease. Director Tan Jing said that vitamin K2, as a safe nutritional supplement, deserves to continue to do a large sample of intervention studies.
Director Tan Jing delivered a speech
Professor Li Shuzhuang of the Department of Physiology, School of Basic Medical Sciences, Dalian Medical University, pointed out in his keynote speech on "Basic Research on the Prevention and Treatment of Inflammatory Bowel Disease with Vitamin K2" that recent epidemiological studies and clinical data results show that human vitamin K status is inversely correlated with the level of circulating inflammatory markers. Based on the high safety and low adverse reaction characteristics of vitamin K2, it is of great significance to study the effect and mechanism of vitamin K2 on pneumonia, which is of great significance for rational clinical application.
Professor Li Shuzhuang delivered a speech
Dr. Chen Jiepeng, Chief Scientist of Shuangjun Biology, introduced in the keynote speech of "New Discoveries and Making Life More Exciting": As the original research enterprise of vitamin K2 in China, Shuangjun Bio promotes industrial development with scientific research and clinical research, implements biological fermentation intelligent manufacturing with lighthouse ecological factory, and slowly opens the global 100 billion vitamin K2 (MK-7) industry with brand raw material ESSEK2 ®.
Dr. Jiepeng Chen delivered a speech
Special appointment ceremony for experts
In the expert forum of scientists, Shuangjun Biotech invited Professor Lin Yiguang and Professor Ma Lihui to join the expert team and cooperate with a number of authoritative experts to carry out scientific research cooperation.
Expert Appointment Ceremony丨See Lin Yiguang (left), Professor Ma Lihui (middle), Dr. Chen Jiepeng (right)
Book launch ceremony
At this forum, the new book "Clinical Vitamin K2 Science" was officially released, and the deputy editor-in-chief of the book, Professor Xu Feng, director of the Vitamin K2 Research Center of Shuangjun Biology and Shenyang Pharmaceutical University, was invited to comment on the new book. "Clinical Vitamin K2 Science" combines the research progress of vitamin K2 and cites a large number of scientific literature, as a continuing medical education textbook of the Chinese Medical Association, and is the pioneering work of Chinese vitamin K2 clinical medicine textbook. "Clinical Vitamin K2" has also been jointly recommended by well-known experts such as Academician Chen Junshi of the Chinese Academy of Engineering, Director Xu Ling and Director Yu Kang of Peking Union Medical College Hospital, and Director Zhang Zhenlin of the Sixth People's Hospital Affiliated to Shanghai Jiaotong University.
New book review 丨Southy professor Xu Feng, director of the Vitamin K2 Research Center of Shenyang Pharmaceutical University
The "New Discoveries in Vitamin K2 Health Evidence" Scientist Forum was successfully concluded. Vitamin K2 has shown an important role in the clinical research and application of many diseases with its revolutionary and versatility, and its health effects have made new progress in the prevention and treatment of osteoporosis, diabetes, kidney disease, enteritis and other diseases.
As a national standard maker of vitamin K2 (fermentation method) and a leading enterprise in the health and nutrition industry, Shuangjun Bio is at the forefront of the industry with its own scientific research strength, and has continuously deepened in the field of vitamin K2 industry, expanding new scenarios for the clinical intervention research and product application of vitamin K2, and contributing to the sustainable development of the entire vitamin K2 industry.
The forum ended with a group photo of experts